Metabolic Associated Fatty Liver Disease Clinical Trial
Official title:
A Multicenter, Retrospective Clinical Study on the Clinical Characteristics of Metabolic Associated Fatty Liver Disease
Metabolic associated fatty liver disease (MAFLD), which can lead to liver fibrosis, cirrhosis, liver failure and even hepatocellular carcinoma, poses a significant burden on society. With the improvement of living standards and changes in dietary habits, MAFLD patients show a younger and increasing trend, but there is still no specific drug. The clinical features and prognosis of MAFLD may be different with different metabolic disorder phenotypes and treatment measures. Therefore, further systematic study of the clinical characteristics and prognosis of MAFLD patients will be of great significance for the formulation of corresponding clinical prevention and treatment strategies.
Metabolic associated fatty liver disease (MAFLD), which can lead to liver fibrosis, cirrhosis, liver failure and even hepatocellular carcinoma, poses a significant burden on society. With the improvement of living standards and changes in dietary habits, MAFLD patients show a younger and increasing trend, but there is still no specific drug. The clinical features and prognosis of MAFLD may be different with different metabolic disorder phenotypes and treatment measures. Therefore, further systematic study of the clinical characteristics and prognosis of MAFLD patients will be of great significance for the formulation of corresponding clinical prevention and treatment strategies. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04871880 -
Lifestyle Modification for MAFLD Based on TTM
|
N/A | |
| Recruiting |
NCT05782972 -
Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study
|
Phase 4 | |
| Recruiting |
NCT05913986 -
Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease
|
N/A | |
| Recruiting |
NCT05597709 -
Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China
|
||
| Not yet recruiting |
NCT06180928 -
Short Term Outcome of Metabolic Associated Fatty Liver Disease (MAFLD) in Patients Undergoing Bariatric Surgery
|
||
| Completed |
NCT04761900 -
MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes
|
||
| Not yet recruiting |
NCT05738707 -
Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease
|
||
| Recruiting |
NCT04573283 -
A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China
|